Literature DB >> 10601304

Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors. Role of C-terminal of receptor alpha subunit.

C Kristensen1, F C Wiberg, A S Andersen.   

Abstract

We have investigated the role of the C-terminal of the alpha-subunit in the insulin receptor family by characterizing chimeric mini-receptor constructs comprising the first three domains (468 amino acids) of insulin receptor (IR) or insulin-like growth factor I receptor (IGFIR) combined with C-terminal domain from either insulin receptor (IR) (residues 704-719), IGFIR, or insulin receptor-related receptor (IRRR). The constructs were stably expressed in baby hamster kidney cells and purified, and binding affinities were determined for insulin, IGFI, and a single chain insulin/IGFI hybrid. The C-terminal domain of IRRR was found to abolish binding in IR and IGFIR context, whereas other constructs bound ligands. The two constructs with first three domains of the IR demonstrated low specificity for ligands, all affinities ranging from 3.0 to 15 nM. In contrast, the constructs with the first three domains of the IGFIR had high specificity, the affinity of the novel minimized IGFIR for IGFI was 1.5 nM, whereas the affinity for insulin was more than 3000 nM. When swapping the C-terminal domains in either receptor context only minor changes were observed in affinities (<3-fold), demonstrating that the carboxyl-terminal of IR and IGFIR alpha-subunits are interchangeable and suggesting that this domain is part of the common binding site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601304     DOI: 10.1074/jbc.274.52.37351

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists.

Authors:  Brian J Smith; Kun Huang; Geoffrey Kong; Shu Jin Chan; Satoe Nakagawa; John G Menting; Shi-Quan Hu; Jonathan Whittaker; Donald F Steiner; Panayotis G Katsoyannis; Colin W Ward; Michael A Weiss; Michael C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-26       Impact factor: 11.205

2.  In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.

Authors:  Mark R Sommerfeld; Günter Müller; Georg Tschank; Gerhard Seipke; Paul Habermann; Roland Kurrle; Norbert Tennagels
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 3.  A thing of beauty: Structure and function of insulin's "aromatic triplet".

Authors:  Michael A Weiss; Michael C Lawrence
Journal:  Diabetes Obes Metab       Date:  2018-09       Impact factor: 6.577

Review 4.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

5.  The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Authors:  Meizhen Lou; Thomas P J Garrett; Neil M McKern; Peter A Hoyne; V Chandana Epa; John D Bentley; George O Lovrecz; Leah J Cosgrove; Maurice J Frenkel; Colin W Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

6.  Insulin receptor-related receptor as an extracellular alkali sensor.

Authors:  Igor E Deyev; Fabien Sohet; Konstantin P Vassilenko; Oxana V Serova; Nadezhda V Popova; Sergey A Zozulya; Elena B Burova; Pascal Houillier; Dmitry I Rzhevsky; Anastasiya A Berchatova; Arkady N Murashev; Anton O Chugunov; Roman G Efremov; Nikolai N Nikol'sky; Eugenio Bertelli; Dominique Eladari; Alexander G Petrenko
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

7.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

8.  The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein.

Authors:  Lindsay A Pfeffer; Becky K Brisson; Hanqin Lei; Elisabeth R Barton
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

9.  A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.

Authors:  Clair L Alvino; Kerrie A McNeil; Shee Chee Ong; Carlie Delaine; Grant W Booker; John C Wallace; Jonathan Whittaker; Briony E Forbes
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

Review 10.  Optimizing IGF-I for skeletal muscle therapeutics.

Authors:  Anastassios Philippou; Elisabeth R Barton
Journal:  Growth Horm IGF Res       Date:  2014-06-19       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.